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Abstract
Purpose: To evaluate the incidences and influencing factors of pneumothorax and parenchymal haemorrhage after 
computed tomography (CT)-guided transthoracic needle biopsy (TTNB).
Material and methods: A retrospective analysis of 216 patients who underwent CT-guided TTNB was performed.  
The frequencies and risk factors of pneumothorax and parenchymal haemorrhage were determined. P values less 
than 0.05 were considered statistically significant.
Results: The incidences of pneumothorax and parenchymal haemorrhage were 23.1% and 45.4%, respectively. Twen-
ty-two per cent of patients with pneumothorax needed percutaneous drainage, but all patients with parenchymal 
haemorrhage had clinical improvement after conservative treatment. No procedure-related mortality was detected. 
Univariate analysis showed that underlying pulmonary infection, lesion size of less than 1 cm, and lesion depth of 
more than 2 cm were significant influencing factors of pneumothorax. A significant relationship between the un-
derlying chronic obstructive pulmonary disease (COPD) and the need for drainage catheter insertion was found. 
Pulmonary haemorrhage was more likely to occur in patients with underlying malignancy, solid pulmonary nodule, 
lesion size of 3 cm or less, and lesion depth of more than 3 cm. Consolidation was the protective factor for pulmonary 
haemorrhage. Sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV), and 
accuracy of CT-guided core needle biopsy (CNB) for the diagnosis of malignancy were 95.7%, 100%, 100%, 93.3%, 
and 97.3%, respectively. The rate of diagnostic failure was 10.2%.
Conclusions: Pulmonary hemorrhage is the most common complication after CT-guided TTNB. Influencing factors for 
pneumothorax are underlying pulmonary infection, lesion size < 1 cm, and lesion depth > 2 cm. Underlying malignancy, 
solid pulmonary nodule, lesion size ≤ 3 cm, and lesion depth > 3 cm are associated with pulmonary haemorrhage.
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Introduction
Advances in computed tomography (CT) technology have 
resulted in increased detection of the smaller pulmonary 
and mediastinal lesions. According to the Fleischner Soci-
ety 2017 guidelines for management of incidental pulmo-
nary nodules detected on CT images, a solid solitary pul-
monary nodule that is larger than 8 mm requires further 
work up of either three-month follow-up with CT, posi-
tron emission tomography/computed tomography (PET/
CT), invasive procedures for diagnosis, or a combination 
thereof [1]. The invasive procedures include transthorac-
ic needle biopsy (TTNB) and transbronchial needle as-
piration (TBNA), depending on the lesion locations and 
characteristics.
TTNB is a widely accepted procedure for definitive 
diagnosis of both benign and malignant lesions. TTNB 
can be performed under imaging guidance by several 
modalities including ultrasound, fluoroscopy, conven-
tional CT, CT fluoroscopy, or cone-beam CT. Both fine 
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needle aspiration (FNA) and core needle biopsy (CNB) 
can be obtained. FNA has high sensitivity, specificity, and 
accuracy for the diagnosis of malignancy, but it achieves 
definitive diagnosis of the benign lesion in less than half 
of the cases. CNB increases the rate of definitive diagnosis 
of the benign lesion to as much as 90% [2]. The reported 
range of the success rate of TTNB for pulmonary lesions 
is about 77-96% [3].
Pneumothorax and pulmonary haemorrhage are the 
two most common minor complications after CT-guid-
ed lung biopsy, ranging from 22.2% to 28.6% and 13.4% 
to 23.8%, respectively [4]. The other complications are 
haemothorax, haemoptysis, and dyspnoea. In the reported 
cases, tumour seeding and air embolism could occur [5,6].
Various factors contributing to these complications 
have been investigated, such as elderly patients, patients 
who have emphysema or bullae, deep lesion, small lesion, 
needle traversing emphysema or bullae, depth of needle 
traversing the aerated lung, needle traversing fissure, angle 
of needle with parietal pleura, size of the needle, coaxial or 
noncoaxial technique, rapid needle out, and rolling back 
[7-10]. The factors that were mostly stated in the previous 
literature are deep lesion, small lesion, presence of emphy-
sema along the needle tract, and transfissural approach.
While there are many literatures references to the di-
agnostic yield and complications of transthoracic needle 
biopsy, reports detailing CT-guided thoracic biopsy in the 
Thai population remain limited. This study is primarily 
aimed at evaluating the incidence of pneumothorax and 
parenchymal haemorrhage after CT-guided transthoracic 
biopsy and influencing factors that relate to these compli-
cations at a single institution. The secondary purpose is 
to determine the diagnostic accuracy of the biopsy proce-
dure and the rate of diagnostic failure.
Material and methods
Patient selection
This study was approved by the Human Ethics Committee 
of our institute. All biopsy procedures under CT guid-
ance from March 2015 to June 2017 were retrospectively 
reviewed from the Radiology Information System. The 
inclusion criteria were patients who underwent TTNB 
and had available images of the preoperative multidetec-
tor computed tomography (MDCT) of the chest on the 
Picture Archiving and Communication System (PACS) 
of the hospital. The exclusion criteria were patients who 
had no CT imaging of the procedure on the PACS or had 
incomplete procedural data.
Biopsy procedure
All patients must have acceptable coagulogram before the 
biopsy procedure. Antiplatelet drugs and anticoagulants 
were discontinued at least seven days prior the procedure. 
Patients were informed about the purpose, process of the 
biopsy procedure, probability of the complications after 
the procedure, and the proper management.
TTNBs were performed under CT guidance, using 
a 128-slice CT system (Somatom Definition AS, Siemens, 
Berlin and München, Germany) by one of two interven-
tional radiologists (three years’ and 13 years’ experience 
in image-guided TTNB). After the operator reviewed the 
latest CT images and the patient’s conditions, the patient 
was positioned properly. CT scan was obtained to detect 
the target lesion. The most appropriate and safest pathway 
to the target lesion was determined. The skin marker was 
attached to the estimated skin entry site. A CT scan was 
performed again to establish the exact skin entry site, cor-
related with the skin marker, and to measure the depth 
from the skin entry site to the target lesion. The skin mark-
er was then removed, and the skin was prepared using ster-
ile technique, and 1% lidocaine was used for local anaes-
thesia. The operator assigned the angle between the needle 
and the chest wall and then inserted a 19-gauge coaxial 
introducer pointing the target lesion. After confirming 
the needle position by repeated CT scanning, a 20-gauge 
semiautomated cutting needle (Biofeather, Medax Medi-
cal Device, Italy) was inserted into the lesion through the 
coaxial introducer, and the biopsy was performed. The de-
cision to perform CNB only, FNA only, or both CNB and 
FNA was operator dependent. The tissue obtained from 
the CNB was then put in the 10% formalin solution, and 
the specimen obtained from the FNA was sprayed on to 
the slide and then placed in the 95% ethyl alcohol. Some of 
the specimen was sent as air-dried for additional analysis 
such as special staining or culture. Immediate postproce-
dural CT was performed to detect complications.
The patient was observed for any clinical symptoms 
for at least two hours. Chest radiograph was routinely ob-
tained at two hours after the procedure. In cases of pres-
ence of pneumothorax, a subsequent two-hour follow-up 
radiograph was performed. Patients with minimal pneu-
mothorax or pulmonary haemorrhage without symptoms 
were advised and then discharged. A drainage catheter 
was inserted in cases of pneumothorax with symptoms or 
in cases of progressive pneumothorax on the follow-up 
imaging, both depending on clinical judgement.
Data collection
One board-certified interventional radiologist and an at-
tending radiology resident retrospectively reviewed the 
latest chest CT before the biopsy and the CT of the bi-
opsy procedure. The latest preprocedural chest CT was 
reviewed in the axial, coronal, and sagittal planes with 
slice thickness of 2.5-5 mm. The origin of the target lesion, 
indication of biopsy, lesion size and characteristics, and 
lesion location were recorded. Lesion size was defined as 
the mean diameter of the two maximal diameters meas-
ured on axial image.
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The CT images of the biopsy procedure were reviewed 
in the axial plane with a slice thickness of 2.5 mm. The 
procedural information including the patient’s position, 
depth and angle of the needle path, and emphysema or 
fissure passed by the needle were documented. The lesion 
depth was measured from the pleura to the surface of the 
target lesion along the needle path. The “needle-pleural 
angle” was defined as the angle between the needle and 
the line perpendicular to the pleural surface at the needle 
entry point [8] (Figure 1).
Pneumothorax and pulmonary haemorrhage as well 
as management were recorded based on the immediate 
CT after biopsy procedure, the first follow-up chest radi-
ograph, and the medical records. The maximal thickness 
of the pneumothorax was measured on the immediate 
post-procedural CT images. Pulmonary haemorrhage 
was defined as a new consolidative or ground-glass opac-
ity on the post-biopsy imaging along the needle tract 
or surrounding the lesion, either on CT or chest radi-
ograph. The haemorrhage was classified into two types: 
type I was haemorrhage along the needle tract and type 
II was haemorrhage surrounding the pulmonary lesion 
with or without haemorrhage along the needle tract [11] 
(Figure 2).
Pathological results from the CNB, cytological results 
from the FNA, pathological results from the surgical spec-
imen in cases of undergoing surgical resection, the clinical 
and imaging follow-up, as well as the management of pa-
tients with complications after procedures, were obtained 
from the Hospital Information System.
Assessment of diagnostic accuracy
The final diagnosis, as the reference, of the target lesion 
was concluded as one of the three categories as follows: 
(1) malignancy, (2) benign, and (3) indeterminate. The 
criteria for malignancy were surgical specimen show-
ing malignancy, pathological result from CNB revealing 
malignancy, or follow-up imaging showing progression 
of a pulmonary lesion that was considered to be lung 
metastasis. The criteria for benignity were surgical spec-
imen showing benignity, pathological result from CNB 
revealing benign lesion, or follow-up imaging showing 
decreased size of the lesion of 20% or more without any 
data of treatment of malignancy.
The pathological result from CNB and the cytological 
result from FNA were recorded, and then the concord-
ance was determined. The pathological result from CNB 
was subclassified into five categories as follows: (1) ma-
lignancy, (2) specific benign lesion such as haematoma, 
(3) nonspecific benignity such as granuloma, chronic in-
flammation, and fibrosis, (4) infection such as tuberculo-
sis, and (5) non-diagnostic result. The cytological result 
from FNA was classified into three categories as follows: 
(1) malignancy, and (2) benign and (3) non-diagnostic 
results. Diagnostic failure was defined as a pathological 
result from CNB being non-diagnostic result or revealing 
a false negative result according to the criteria for malig-
nancy.
Statistical analysis
SPSS version 23.0 for Windows (SPSS Inc., Chicago, 
Illinois, USA) was used for statistical analysis. Univariate 
analysis with X2 or Fisher exact test for categorical var-
iables and Student’s t-test for continuous variables were 
performed to evaluate whether study variables were sig-
nificantly different between groups regarding complica-
tions of the biopsy procedure. The threshold for statistical 
significance was set at a P value of less than 0.05. The sen-
sitivity, specificity, positive predictive values (PPV), neg-
ative predictive values (NPV), and accuracy of the CNB 
and FNA were calculated by using 2 × 2 tables.
Figure 1. The “needle-pleural angle”. Line A was tangential to the pleural 
surface at the needle entry point. Line B was perpendicular to the line A at 
the needle entry point. The needle-pleural angle was defined as the angle 
between the needle and line B
Figure 2. Types of pulmonary haemorrhage. Type I was haemorrhage along 
the needle tract, type II was haemorrhage surrounding the lesion with or 
without haemorrhage along the needle tract
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Results
Study population
From March 2015 to June 2017 there were 216 patients 
(mean age: 62.6 ±14.4 years, range: 16 to 89 years) un-
dergoing CT-guided TTNB. There were 126 male patients 
(mean age: 63 ±14.6 years) and 90 female patients (mean 
age: 62.2 ±14.3 years).
Lesion characteristics
Biopsies of 194 pulmonary, 13 mediastinal, and nine 
pleural lesions were performed. Among all pulmonary le-
sions, there were 153 solid nodules, nine subsolid nodules, 
19 consolidations, and 13 cavitary lesions. Indications for 
lung biopsy were solitary lesion (n = 118, 60.8%), multi-
ple lesions (n = 64, 33.0%), and focal infiltration (n = 12, 
6.2%). The mean size of the pulmonary lesions was 3.1 
±2.0 cm (range: 0.4-10.7 cm).
Complications
Pneumothorax occurred in 50 patients (23.1%). Among 
these, there were 11 patients (22.0% of patients with pneumo-
thorax and 5.1% of all procedures) who needed percutaneous 
drainage. The durations of retaining drainage catheter ranged 
from two to 30 days (median five days). Two of these 50 pa-
tients (4%) did not have pneumothorax on the immediate 
CT scan but later developed pneumothorax on the follow-up 
chest radiograph: one at five hours after the procedure with 
maximal pneumothorax thickness of 2.1 cm; and the another 
at two hours after the procedure with maximal pneumotho-
rax thickness of  0.6 cm. None of them required chest drain.
Pulmonary haemorrhage was found in 98 patients 
(45.4%), which were classified as type I (n = 29, 29.6%) 
and type II (n = 69, 70.4%). All had clinical improvement 
after conservative treatment (Figure 3). There were 22 pa-
tients (10.2%) with both pneumothorax and pulmonary 
haemorrhage after the procedure. No procedure-related 
mortality was detected.
Figure 3. Chest CT and chest radiograph of a 67-year-old male with underlying chronic lung disease, who underwent CT-guided lung biopsy of a 1.8-cm 
nodule at left upper lobe (LUL). A) Chest CT during the procedure. B) Immediate chest CT after the procedure showed pulmonary haemorrhage type II. 
C) Chest radiograph 2 hours after the procedure showed patchy opacity at LUL, representing pulmonary haemorrhage. The patient had minimal haemoptysis 
and self-recovery during close clinical observation. One day after biopsy, the patient was discharged. D) Follow-up chest radiograph 2 months after the 
procedure showed disappearance of the opacity at LUL
A
C
B
D
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 Factors associated with complications
The incidence of pneumothorax significantly increased in 
patients with underlying pulmonary infection (p = 0.008), 
small lesion size (p = 0.001), and increased needle length 
traversing lung parenchyma (p = 0.036) (Tables 1 and 2). 
Lesion size of less than 1 cm showed significantly increased 
rate of pneumothorax (p = 0.031). Conversely, lesion size 
of more than 3 cm showed significantly decreased rate of 
pneumothorax (p = 0.027). Pneumothorax was more likely 
to occur with the needle length traversing lung parenchy-
ma of more than 2 cm (p = 0.024). There was no statis-
tically significant association between the pneumothorax 
thickness and the need of drainage catheter insertion 
(p = 0.186). However, a significant relation between un-
derlying chronic obstructive pulmonary disease (COPD) 
and the need for drainage catheter insertion was found 
(p = 0.009) (Figure 4, Table 3).
Higher rate of pulmonary haemorrhage was signifi-
cantly correlated with underlying malignancy (p < 0.001), 
small lesion size (p < 0.001), increased needle length 
traversing lung parenchyma (p < 0.001), and solid nodule 
(p < 0.001). Lesion size of 3 cm or less and lesion depth 
of more than 3 cm revealed significantly increased rate of 
pulmonary haemorrhage (p < 0.001). Patients with con-
solidative lesion had significantly lower incidence of pul-
monary haemorrhage (p = 0.007) (Tables 4 and 5).
Diagnostic accuracy
Among the total of 216 lesions, 119 were malignancy (88 
primary lung cancers and 31 lung metastases), 76 were 
benign (three thymoma, one thymic cyst, one spindle 
cell tumour, four tuberculosis, four fungal infection, and 
63 nonspecific infection and inflammation), and 21 were 
indeterminate.
The final diagnosis of malignancy was made based on 
surgical pathology (n = 9), specific malignant result from 
CNB (n = 103), and evidence of progression of the pulmo-
nary lesion on follow-up imaging (n = 7). The final diag-
nosis of benignity was made based on surgical pathology 
(n = 1), specific benign result from CNB (n = 9), and sig-
nificantly decreased size on the follow-up imaging (n = 66).
CNBs were performed in all lesions, whereas FNAs 
were done in 133 of 216 lesions (61.6%). Pathological re-
sults from CNB were malignancy (n = 112, 51.9%), spe-
cific benign result (n = 9, 4.1%), nonspecific benign lesion 
(n = 71, 32.9%), infection (n = 7, 3.2%), and non-di-
agnostic result (n = 17, 7.9%). Cytological results from 
FNA were malignancy (n = 73, 54.9%), benignity (n = 37, 
27.8%), and non-diagnostic result (n = 23, 17.3%).
There were five false-negative cases in CNB. Sensitivi-
ty, specificity, PPV, NPV, and accuracy of the CNB for the 
diagnosis of malignancy were 95.7%, 100%, 100%, 93.3%, 
and 97.3%, respectively. There were three false-positive 
cases and four false-negative cases in FNA. Sensitivity, 
Table 1. Univariate analysis of selected variables according to patient and 
lesion characteristics as risk factors for pneumothorax after CT-guided TTNB 
(n = 216)
Variables With 
pneumothorax 
(n = 50)*
Without 
pneumothorax 
(n = 166)*
P value
Gender 0.354
 Male 32 (64.0) 94 (56.6)
 Female 18 (36.0) 72 (43.4)
Age (y)** 63.1 ±13.9 62.5 ±14.6 0.778
Underlying disease
COPD 8 (16.0) 20 (12.0) 0.466
Pulmonary 
infection
12 (24.0) 16 (9.6) 0.008
Chronic lung 
disease
5 (10.0) 6 (3.6) 0.133
Pulmonary arterial 
hypertension
3 (6.0) 13 (7.8) 1.000
Pulmonary venous 
hypertension
1 (2.0) 0 (0.0) 0.231
On ventilator 2 (4.0) 0 (0.0) 0.053
Underlying 
malignancy
20 (40.0) 59 (35.5) 0.566
Lesion size (cm)** 2.6 ±1.5 3.5 ±2.2 0.001
Lesion size 0.023
< 1 cm 9 (18.0) 12 (7.2)
1-3 cm 24 (48.0) 68 (41.0)
> 3 cm 17 (34.0) 86 (51.8)
Lesion depth (cm)** 2.5 ±1.6 1.9 ±1.9 0.050
Lesion depth 0.036
0 cm 5 (10.0) 53 (31.9)
0.1-1.0 cm 6 (12.0) 13 (7.8)
1.1-2.0 cm 12 (24.0) 40 (24.1)
2.1-3.0 cm 7 (14.0) 10 (6.0)
> 3.0 cm 20 (40.0) 50 (30.1)
Lesion location*** 0.124
RUL 11 (23.4) 49 (33.3)
RML 4 (8.5) 5 (3.4)
RLL 16 (34.0) 29 (19.7)
LUL 8 (17.0) 36 (24.5)
LLL 8 (17.0) 28 (19.0)
Lesion abutting 
fissure
11 (22.0) 38 (22.9) 0.895
*Data are numbers of patients, with percentages in parentheses.
**Data are means ± standard deviations.
***Lesion location was analysed only for lesions with pulmonary origin.
CT – computed tomography, TTNB – transthoracic needle biopsy, COPD – chronic obstructive 
pulmonary disease, RUL – right upper lobe, RML – right middle lobe, RLL – right lower lobe, 
LUL – left upper lobe, LLL – left lower lobe
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specificity, PPV, NPV, and accuracy of the FNA for the di-
agnosis of malignancy were 94.4%, 90.9%, 95.7%, 88.2%, 
and 93.3%, respectively. The concordance between CNB 
and FNA was 98 of 105 (93.3%). Seventeen non-diagnos-
tic results and five false-negative results from CNB result-
ed in a total of 22 (10.2%) cases of diagnostic failure.
Discussion
In our study, the rate of pulmonary haemorrhage was 
45.4%. Although the rate was slightly high, it was com-
parable with the previous reported rates from two large 
studies, ranging from 26.8% to 41.1% [11,12]. None of 
these cases needed further intervention. The rates of 
pneumothorax and chest tube placement for pneumotho-
rax were 23.1% and 5.1% of the procedures, respectively. 
These rates are within the estimated ranges published in 
Quality improvement guidelines for percutaneous needle bi-
opsy [3], which reported the rate of pneumothorax of 12% 
to 45% and set the threshold for chest tube placement for 
pneumothorax of 2.0% to 15.0%. The median duration of 
chest tube insertion in our study was five days (ranging 
from two to 30 days). We found that patients with under-
lying COPD who developed pneumothorax after TTNB 
were more likely to have chest tube drainage insertion (p 
= 0.009), which could be explained by increased airway 
pressure in pulmonary emphysema, resulting in persis-
tent air leakage. Hiraki et al. [13] similarly reported way 
that pulmonary emphysema and deep lesion significantly 
increased the rate of chest tube placement for the patient 
with pneumothorax. Brandén et al. [14] stated a high rate 
of chest tube insertion (57% of patients with pneumotho-
rax after TTNB) in patients with FEV1 < 35%.
In this study, we found two out of 216 patients (0.9%) 
developed pneumothorax, which was later detected on the 
follow-up chest radiograph at two hours and five hours. 
This rate was analogous to the reported rate of delayed 
pneumothorax, varying from 0.7% to 3.3% [15,16]. Choi 
et al. [15] reported that the time of the detection of de-
layed pneumothorax ranged between five and 120 hours 
after biopsy, and only 40% of patients with delayed pneu-
mothorax developed chest symptoms. Previous studies 
also showed that initial covert pneumothorax sometimes 
required chest tube insertion [15-18]. Because chest radi-
Table 2. Univariate analysis of selected variables according to biopsy pro-
cedure as risk factors for pneumothorax after CT-guided TTNB (n = 216)
Variable With 
pneumothorax 
(n = 50)*
Without 
pneumothorax 
(n = 166)*
P value
Patient’s position 0.573
Supine 21 (42.0) 84 (50.6)
Prone 26 (52.0) 77 (46.4)
Lateral decubitus 2 (4.0) 4 (2.4)
Oblique 1 (2.0) 1 (0.6)
Puncture site 0.511
Anterior 9 (18.0) 44 (26.5)
Anterolateral 8 (16.0) 31 (18.7)
Lateral 5 (10.0) 10 (6.0)
Posterior 25 (50.0) 67 (40.4)
Posterolateral 3 (6.0) 14 (8.4)
Needle angle 0.957
< 60° 26 (52.0) 87 (52.4)
> 60° 24 (48.0) 79 (47.6)
Emphysema passed 
on the needle 
pathway
4 (8.0) 6 (3.6) 0.245
Fissure passed on the 
needle pathway
2 (4.0) 4 (2.4) 0.625
Biopsy technique 0.510
Core biopsy 17 (34.0) 65 (39.2)
Core biopsy with 
FNA
33 (66.0) 101 (60.8)
FNA – fine needle aspiration, CT – computed tomography, TTNB – transthoracic needle biopsy
Table 3. Univariate analysis of selected variables as associated factors for 
retaining drainage catheter in patients with pneumothorax (n = 50)
Variables With 
drainage 
catheter
(n = 11)*
Without 
drainage 
catheter
 (n = 39)*
P value
Gender 0.287
Male 9 (81.8) 23 (59.0)
Female 2 (18.2) 16 (41.0)
Age (y)** 62.6 ±13.5 63.3 ±14.1 0.893
Underlying disease
COPD 5 (45.5) 3 (7.7) 0.009
Pulmonary infection 2 (18.2) 10 (25.6) 1.000
Chronic lung disease 3 (27.3) 2 (5.1) 0.064
Pulmonary arterial 
hypertension
1 (9.1) 2 (5.1) 0.534
Pulmonary venous 
hypertension
0 (0.0) 1 (2.6) 1.000
On ventilator 1 (9.1) 1 (2.6) 0.395
Underlying malignancy 5 (45.5) 15 (38.5) 0.736
Lesion size (cm)** 2.4 ±1.5 2.6 ±1.5 0.701
Lesion depth (cm)** 2.6 ±1.4 2.5 ±1.7 0.861
Lesion abutting fissure 1 (9.1) 10 (25.6) 0.416
Pneumothorax 
thickness (cm)**
1.17 ±1.17 0.66 ±0.51 0.186
COPD – chronic obstructive pulmonary disease
*Data are numbers of patients, with percentages in parentheses.
**Data are means ± standard deviations.
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ograph can miss a significant number of pneumothorax 
cases after CT-guided lung biopsy [18] and some delayed 
pneumothorax needs further intervention, these can re-
flect that both immediate CT after biopsy and follow-up 
chest radiograph are still necessary. In addition, health-
care providers should inform patients about the symp-
toms of pneumothorax before discharge, which may help 
in early detection of delayed pneumothorax.
Our study showed that needle length traversing lung 
parenchyma of more than 2 cm, lesion size of less than 1 
cm, and underlying pulmonary infection were the signif-
icant risk factors of pneumothorax. These could be due 
to increased difficulty in accurate placement of the nee-
dle into a target lesion that was small and deeply located, 
resulting in an increased number of needle redirections, 
increased amount of traversed lung parenchyma, or in-
Figure 4. Chest CT and chest radiograph of a 77-year-old male with un-
derlying chronic obstructive pulmonary disease (COPD), who underwent 
CT-guided lung biopsy of a 2.3-cm spiculate nodule at left upper lobe (LUL). 
A) Chest CT during the procedure in supine position. B) Immediate chest CT 
after the procedure showed pneumothorax. C) Chest radiograph 2 hours 
after the procedure showed progression of pneumothorax with left lung 
collapse. The patient developed dyspnea during observation. D) Drainage 
catheter insertion was performed. E) The catheter could be removed 6 days 
after the procedure. Chest radiograph after catheter removal showed ex-
panded emphysematous lung
A
C
E
D
B
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Table 4. Univariate analysis of selected variables according to patient 
and lesion characteristics as risk factors for pulmonary hemorrhage after 
CT-guided TTNB (n = 216)
Variables With 
parenchymal 
hemorrhage 
(n = 98)*
Without 
parenchymal 
hemorrhage 
(n = 118)*
P value
Gender 0.548
Male 55 (56.1) 71 (60.2)
Female 43 (43.9) 47 (39.8)
Age (y)** 63.7 ±12.9 61.8 ±15.6 0.332
Underlying disease
COPD 16 (16.3) 12 (10.2) 0.180
Pulmonary 
infection
13 (13.3) 15 (12.7) 0.904
Chronic lung 
disease
7 (7.1) 4 (3.4) 0.232
Pulmonary arterial 
hypertension
7 (7.1) 9 (7.6) 0.892
Pulmonary venous 
hypertension
0 (0.0) 1 (0.8) 1.000
On ventilator 1 (1.0) 1 (0.8) 1.000
Underlying 
malignancy
49 (50.0) 30 (25.4) < 0.001
Lesion size (cm)** 2.3 ±1.6 4.2 ±2.1 < 0.001
Lesion size < 0.001
< 1 cm 19 (19.4) 2 (1.7)
1-3 cm 56 (57.1) 36 (30.5)
> 3 cm 23 (23.5) 80 (67.8)
Lesion depth (cm)** 2.9 ±1.8 1.3 ±1.5 < 0.001
Lesion depth < 0.001
0 cm 4 (4.1) 54 (45.8)
0.1-1.0 cm 7 (7.1) 12 (10.1)
1.1-2.0 cm 28 (28.6) 24 (20.3)
2.1-3.0 cm 9 (9.2) 8 (6.8)
> 3.0 cm 50 (51.0) 20 (16.9)
Lesion location*** 0.366
RUL 28 (29.2) 32 (32.7)
RML 7 (7.3) 2 (2.0)
RLL 22 (22.9) 23 (23.5)
LUL 19 (19.8) 25 (25.5)
LLL 20 (20.8) 16 (16.3)
Lesion 
characteristics***
< 0.001
Solid 81 (82.7) 72 (61.0)
Subsolid 7 (7.1) 2 (1.7)
Consolidation 3 (3.1) 16 (13.6)
Cavity 5 (5.1) 8 (6.8)
*Data are numbers of patients, with percentages in parentheses.
**Data are means ± standard deviations.
***Lesion location and lesion characteristics were analysed only lesions with pulmonary in origin.
CT – computed tomography, TTNB – transthoracic needle biopsy, COPD – chronic obstructive 
pulmonary disease, RUL – right upper lobe, RML – right middle lobe, RLL – right lower lobe, 
LUL – left upper lobe, LLL – left lower lobe
Table 5. Univariate analysis of selected variables according to biopsy pro-
cedure and final diagnosis as risk factors for pulmonary haemorrhage after 
CT-guided TTNB (n = 216)
Variables With 
parenchymal 
haemorrhage 
(n = 98)*
Without 
parenchymal 
haemorrhage 
(n = 118)*
P value
Emphysema passed 
on the needle 
pathway
5 (5.1) 1 (0.1) 0.095
Fissure passed on the 
needle pathway
7 (7.1) 3 (2.5) 0.191
Biopsy technique 0.954
Core biopsy 37 (37.8) 45 (38.1)
Core biopsy with 
FNA
61 (62.2) 73 (63.5)
Final diagnosis 0.516
Malignancy 53 (54.1) 66 (55.9)
Benign 33 (33.7) 43 (36.4)
Unknown 12 (12.2) 9 (7.6)
*Data are numbers of patients, with percentages in parentheses.
FNA – fine needle aspiration
creased dwelling time of the needle. However, there was 
no recorded data about the number of needle redirections 
in our study. Patients with underlying pulmonary infection 
probably could not hold their breath well enough, lead-
ing to technical difficulties. The results of our study are in 
parallel with the large retrospective review by Yeow et al. 
[9], which stated that a lesion size of ≤ 2 cm had increased 
pneumothorax rate. However, they reported that a lesion 
depth of 0.1 to 2 cm had higher risk of pneumothorax than 
a lesion depth of ≥ 2.1 cm. They postulated that biopsy of 
the subpleural lesion was difficult to perform and suggest-
ed that the use of a longer oblique transpulmonary needle 
path could reduce the risk of pneumothorax. In contrast, 
other authors who have analysed the depth of the needle 
path have described an increasing rate of pneumothorax 
with greater lesion depth [13,19].
To decrease the rates of pneumothorax, Kinoshita et 
al. [20] suggested that rolling the patient with biopsy site 
down for 15 minutes, using a special table, could decrease 
the pneumothorax rate as compared to the standard pro-
cedure. Sealing the needle track using autologous blood 
clot could reduce incidence of pneumothorax and may 
decrease the severity of pneumothorax [21]. Moreover, 
the use of CT-fluoroscopy-guided biopsy could provide 
lower complication rate due to nearly real-time imaging 
obtained during needle insertion, resulting in shorter pro-
cedural time and fewer needle passages [22,23].
For pulmonary haemorrhage, we found that needle 
length traversing lung parenchyma of more than 3 cm, 
lesion size of 3 cm or less, solid lesion, and underlying 
malignancy were the significant risk factors. These can be 
 Factors of pneumothorax and parenchymal haemorrhage after TTNB
e387© Pol J Radiol 2018; 83: e379-e388
explained in a similar way to the risk factors of pneumo-
thorax. Patients with underlying malignancy probably had 
impaired or decreased platelet function due to their previ-
ous or on-going treatment and might have had other con-
founding comorbidities that predispose them to bleeding. 
Increased sample size with subgroup analysis may prove 
this hypothesis. The consolidative lesion showed signifi-
cantly decreased pulmonary haemorrhage, probably be-
cause it contained less vascularity and the contents within 
the air-space may have decreased the potential space for 
the haemorrhage to expand. Our result is comparable 
with those in previous literature [9,12,24].
Although we found that none of the patients need-
ed further intervention because it is usually self-limited, 
and one study reported that the need of hospitalisation 
for the patients with haemoptysis after TTNB was only 
0.4% [12], patients should be advised to cough to prevent 
airway obstruction from any blood clots and should be 
placed in a decubitus position with the biopsy side down 
to prevent spill of blood into the contralateral lung after 
needle removal [24].
According to the FNA results in our study, there were 
four false negative cases. All of them had the final diag-
nosis of pulmonary metastasis. CNB helped identify the 
definite diagnosis in three of four cases. There was only 
one case that had a false negative result from both FNA 
and CNB, which occurred due to non-targeted biopsy of 
the 0.6-cm nodule. Among three false positive results of 
FNA, CNB correctly discovered benignity in two of the 
three cases. The other had a non-diagnostic result from 
CNB. The rate of non-diagnostic results from CNB (7.9%) 
was also lower than that from FNA (17.3%). These could 
imply that CNB is more accurate than FNA, although 
there was no significant difference in the diagnostic ac-
curacies between FNA and CNB groups. Anderson et al. 
[25] showed that core biopsy was a more accurate meth-
od of tissue sampling than fine needle aspiration and was 
not associated with an excess of complications. However, 
the more recent studies state that diagnostic yield is not 
decreased when using FNA [26], and advances in FNA 
cytology have enabled subtyping of lung cancer in cyto-
logical material [27].
In our study, sensitivity, specificity, PPV, NPV, and 
accuracy of CT-guided TTNB for the diagnosis of ma-
lignancy were 95.7%, 100%, 100%, 93.3%, and 97.3%, re-
spectively. The accuracies of TTNB were 97.0% for pul-
monary lesions, 100% for mediastinal lesions, and 100% 
for pleural lesions. These results are comparable with 
previous studies [28-33]. We found that the diagnostic 
accuracy for lesions smaller than 1 cm was relatively low, 
at about 88.9%. For lesions larger than 1 cm the outcome 
was more favourable, at about 98.2%. This is probably due 
to the fact that precise placement of the needle in small 
lesions is more difficult than in large lesions. Fluoro-CT 
and cone-beam CT guidance seem to increase diagnos-
tic accuracy in small lesions because of the real-time 
imaging guidance and flexibility in entry site selection 
[23,34]. Choi et al. [35] reported that the use of the aspi-
ration alone was an independent risk factor of diagnostic 
failure for pulmonary nodules smaller than 1 cm. Two 
previous studies [36,37] also described the significant 
difference in accuracy of biopsy of the small subpleural 
nodules between using the “oblique path” (tangential 
approach) and right-angle path (direct approach). They 
demonstrated that the tangential approach had higher 
accuracy than the direct approach. They postulated that 
the longer transparenchymal and subcutaneous track of-
fered better needle stability and easier needle redirection 
without additional violation to the pleura. In our study, 
we also found that the diagnostic accuracy for the lesions 
in the lower lobe (94.1%) was relatively low as compared 
to the lesions in the upper and middle lobes (99.0%). It 
is possible that the lesions in the lower lobe have greater 
respiratory motion, resulting in increased difficulty in 
access. An on-site cytopathologist or cytotechnologist, 
who evaluated the adequacy of the tissue samples, might 
also help increase the diagnostic yield for the laboriously 
accessed lesion.
There were some limitations in our study. Firstly, this 
was a retrospective study, which could have an unknown 
bias. We could not organise the follow-up protocol and 
the guideline management of the complications. Secondly, 
we diagnosed COPD, pulmonary hypertension, and pul-
monary infection based only on imaging and medical re-
cords. Thirdly, the biopsy techniques and the choice of tis-
sue sampling were based on the operators’ consideration, 
which might affect the diagnostic yield and complications. 
We believe that further prospective study with standard 
follow-up protocol would be more beneficial in generating 
the guideline for follow-up and hospitalisation.
Conclusions
In conclusion, CT-guided TTNB is a safe procedure and 
has high diagnostic accuracy. The most common com-
plication is pulmonary haemorrhage. Influencing factors 
for pneumothorax are underlying pulmonary infection, 
lesion size less than 1 cm, and lesion depth more than 
2 cm. Underlying malignancy, solid pulmonary nodule, 
lesion size of 3 cm or less, and lesion depth of more than 
3 cm are associated with pulmonary haemorrhage.
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